同和藥業(300636.SZ)擬捐贈18萬元支持奉新縣新型冠狀病毒肺炎疫情防控
格隆匯2月5日丨同和藥業(300636.SZ)公佈,近日全國多地陸續發生了新型冠狀病毒感染的肺炎疫情,為全力支持抗擊疫情,切實履行上市公司社會責任,同意公司以自有資金向奉新縣紅十字會捐贈人民幣18萬元,用於支持奉新縣新型冠狀病毒肺炎疫情防控。(説明:公司最近12個月已捐扶貧資金及關心下一代關愛基金合計6萬元,根據《公司章程》的相關規定,此次董事會最多可決定捐款數為18.53萬元。)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.